Diferencia entre revisiones de «Template:Increased bleeding DDX»
Sin resumen de edición |
|||
| Línea 10: | Línea 10: | ||
*Acquired (Drug Related) | *Acquired (Drug Related) | ||
**[[Warfarin (Coumadin)]] | **[[Warfarin (Coumadin)]] | ||
**[[Unfractionated | **[[Unfractionated heparin]] | ||
**[[Low | **[[Low molecular weight heparin]] (i.e. [[enoxaparin]] (Lovenox), [[dalteparin]]) | ||
**Factor Xa Inhibitors (e.g. [[rivaroxaban]], [[apixaban]], [[fondaparinux]], [[edoxaban]]) | |||
**Direct thrombin inhibitors (e.g. [[dabigatran]], [[argatroban]], [[bivalirudin]]) | |||
*Illness induced | *Illness induced | ||
**[[Vitamin K deficiency]] | **[[Vitamin K deficiency]] | ||
Revisión actual - 17:24 19 sep 2019
Coagulopathy
Platelet Related
- Too few
- Nonfunctional
Factor Related
- Acquired (Drug Related)
- Warfarin (Coumadin)
- Unfractionated heparin
- Low molecular weight heparin (i.e. enoxaparin (Lovenox), dalteparin)
- Factor Xa Inhibitors (e.g. rivaroxaban, apixaban, fondaparinux, edoxaban)
- Direct thrombin inhibitors (e.g. dabigatran, argatroban, bivalirudin)
- Illness induced
- Genetic